Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study

被引：0
|
作者：
Sam Miller
Tania Krumins
Haojin Zhou
Susan Huyck
Jeremy Johnson
Gregory Golm
Steven G. Terra
James P. Mancuso
Samuel S. Engel
Brett Lauring
机构：
[1] SAM Clinical Research Center,
[2] Merck & Co.,undefined
[3] Inc.,undefined
[4] MSD R&D (China) Co.,undefined
[5] Ltd.,undefined
[6] Pfizer,undefined
[7] Inc.,undefined
[8] Pfizer Inc.,undefined
来源：
Diabetes Therapy | 2018年 / 9卷
关键词：
Ertugliflozin; Glycemic control; SGLT2 inhibitor; Sitagliptin; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：253 / 268
页数：15
相关论文
共 50 条
  • [1] Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study
    Miller, Sam
    Krumins, Tania
    Zhou, Haojin
    Huyck, Susan
    Johnson, Jeremy
    Golm, Gregory
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    Lauring, Brett
    DIABETES THERAPY, 2018, 9 (01) : 253 - 268
  • [2] Safety and efficacy of ertugliflozin in combination with sitagliptin in patients with type 2 diabetes inadequately controlled on diet and exercise: the VERTIS SITA trial
    Lauring, B.
    Miller, S. S.
    Krumins, T.
    Zhou, H. J.
    Huyck, S.
    Johnson, J.
    Golm, G.
    Terra, S. G.
    Mancuso, J. P.
    Engel, S. S.
    DIABETOLOGIA, 2017, 60 : S407 - S408
  • [3] Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo-controlled randomized study
    Dagogo-Jack, Samuel
    Liu, Jie
    Eldor, Roy
    Amorin, Guillermo
    Johnson, Jeremy
    Hille, Darcy
    Liao, Yuqin
    Huyck, Susan
    Golm, Gregory
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    Lauring, Brett
    DIABETES OBESITY & METABOLISM, 2018, 20 (03): : 530 - 540
  • [4] Safety and efficacy of ertugliflozin after 52 weeks in patients with type 2 diabetes inadequately controlled on metformin and sitagliptin: VERTIS SITA2 trial extension
    Eldor, R.
    Liu, J.
    Dagogo-Jack, S.
    Amorin, G.
    Johnson, J.
    Liao, Y.
    Huyck, S.
    Golm, G.
    Terra, S. G.
    Mancuso, J. P.
    Engel, S. S.
    Lauring, B.
    DIABETOLOGIA, 2017, 60 : S21 - S21
  • [5] Efficacy and safety of ertugliflozin in subjects with type 2 diabetes mellitus inadequately controlled on the dual combination of metformin and sitagliptin: the VERTIS SITA2 trial
    Lauring, B.
    Eldor, R.
    Liu, J.
    Dagogo-Jack, S.
    Amorin, G.
    Johnson, J.
    Hille, D.
    Huyck, S.
    Golm, G.
    Terra, S.
    Mancuso, J.
    Engel, S. S.
    DIABETOLOGIA, 2016, 59 : S93 - S93
  • [6] Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study
    Grunberger, George
    Camp, Sarah
    Johnson, Jeremy
    Huyck, Susan
    Terra, Steven G.
    Mancuso, James P.
    Jiang, Zhi Wei
    Golm, Gregory
    Engel, Samuel S.
    Lauring, Brett
    DIABETES THERAPY, 2018, 9 (01) : 49 - 66
  • [7] Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study
    Hollander, Priscilla
    Liu, Jie
    Hill, Julie
    Johnson, Jeremy
    Jiang, Zhi Wei
    Golm, Gregory
    Huyck, Susan
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    Lauring, Brett
    DIABETES THERAPY, 2018, 9 (01) : 193 - 207
  • [8] Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study
    George Grunberger
    Sarah Camp
    Jeremy Johnson
    Susan Huyck
    Steven G. Terra
    James P. Mancuso
    Zhi Wei Jiang
    Gregory Golm
    Samuel S. Engel
    Brett Lauring
    Diabetes Therapy, 2018, 9 : 49 - 66
  • [9] Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study
    Priscilla Hollander
    Jie Liu
    Julie Hill
    Jeremy Johnson
    Zhi Wei Jiang
    Gregory Golm
    Susan Huyck
    Steven G. Terra
    James P. Mancuso
    Samuel S. Engel
    Brett Lauring
    Diabetes Therapy, 2018, 9 : 193 - 207
  • [10] Ertugliflozin in older patients with type 2 diabetes: an analysis from VERTIS CV
    Pratley, R. E.
    Cannon, C. P.
    Charbonnel, B.
    Cherney, D. Z. I.
    Cosentino, F.
    McGuire, D. K.
    Shih, W. J.
    Essex, M. N.
    Lawrence, D.
    Jones, P. L. S.
    Liu, J.
    Adamsons, I. A.
    Dagogo-Jack, S.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 30 - 31
12345